Literature DB >> 30940465

Infections with DNA Viruses, Adenovirus, Polyomaviruses, and Parvovirus B19 in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies.

Karam M Obeid1.   

Abstract

Infections due to adenovirus, polyomaviruses (BK and JC viruses), and parvovirus B19 may not be as common as infections due to other DNA viruses, such as cytomegalovirus in patients with hematological malignancies and the recipients of hematopoietic stem cell transplantation. However, these infections may result in life-threatening diseases that significantly impact patients' recovery, morbidity, and mortality. Treating physicians should be aware of the diseases associated with these viruses, the patient populations at increased risk for complications due to these infections, and the available diagnostic and therapeutic approaches.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenovirus; BK virus; Hematologic malignancies; Hematopoietic stem cell transplant; JC virus; Parvovirus B19; Polyomavirus; Therapy

Year:  2019        PMID: 30940465     DOI: 10.1016/j.idc.2019.02.005

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  3 in total

1.  Evaluation of a Next-Generation Sequencing Metagenomics Assay to Detect and Quantify DNA Viruses in Plasma from Transplant Recipients.

Authors:  Soya S Sam; Ralph Rogers; Fizza S Gillani; Gregory J Tsongalis; Colleen S Kraft; Angela M Caliendo
Journal:  J Mol Diagn       Date:  2021-03-09       Impact factor: 5.568

2.  The grim reaper evading modern medicine: aspergillosis, adenovirus, and Hodgkin lymphoma.

Authors:  Larry Nichols; Justin Armstrong; Cody Atkinson
Journal:  Autops Case Rep       Date:  2020-09-02

3.  Immune reconstitution and survival of patients with parvovirus B19 related pure red cell aplasia after haplo-PBSCT.

Authors:  Xiao Zhou; Peiyao Jiang; Lu Gao; Jun Yang; Yu Cai; Yin Tong; Huiying Qiu; Chongmei Huang; Kun Zhou; Xiaowei Xu; Jiahua Niu; Xinxin Xia; Ying Zhang; Chang Shen; Yu Wei; Jie Shao; Xianmin Song; Liping Wan
Journal:  Ann Hematol       Date:  2022-04-09       Impact factor: 4.030

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.